Go Pro
LON:GNS

Genus (GNS) Share Price, News & Analysis

Genus logo
GBX 2,254 -6.00 (-0.27%)
As of 12:09 PM Eastern

About Genus Stock (LON:GNS)

Advanced

Key Stats

Today's Range
2,246
2,298
50-Day Range
1,988
2,318
52-Week Range
1,943
3,220
Volume
66,115 shs
Average Volume
833,651 shs
Market Capitalization
£1.50 billion
P/E Ratio
31.75
Dividend Yield
1.46%
Price Target
GBX 3,216.67
Consensus Rating
Buy

Company Overview

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Genus Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

GNS MarketRank™: 

Genus scored higher than 63% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Genus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    Genus has a consensus price target of GBX 3,216.67, representing about 42.7% upside from its current price of GBX 2,254.

  • Amount of Analyst Coverage

    Genus has only been the subject of 1 research reports in the past 90 days.

  • Read more about Genus' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Genus is 31.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.29.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Genus is 31.75, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 46.71.

  • Price to Earnings Growth Ratio

    Genus has a PEG Ratio of 2.87. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Genus has a P/B Ratio of 2.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for GNS.
  • Dividend Yield

    Genus pays a meaningful dividend of 1.46%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Genus does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Genus is 45.07%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Genus' dividend.
  • Search Interest

    Only 3 people have searched for GNS on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net £49,990.40 in company stock, which represents 0.0033% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Genus insiders have bought more of their company's stock than they have sold. Specifically, they have bought £49,990.40 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    0.71% of the stock of Genus is held by insiders.

  • Percentage Held by Institutions

    51.90% of the stock of Genus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Genus' insider trading history.
Receive GNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GNS Stock News Headlines

I’m sharing my top day trading secrets for free
A 30-year trading veteran who managed multi-million-dollar hedge funds and wealth for one of the world's richest families is sharing his day trading rules for free. His approach includes the criteria behind a 94.5% win rate, methods for spotting quality stocks already moving higher, and tips for avoiding cutting winners too early.tc pixel
UK Stock Market News: Rank, Watches of Switzerland, Genus
Genus (GNS) Stock Forecast & Price Target
See More Headlines

GNS Stock Analysis - Frequently Asked Questions

Genus' stock was trading at GBX 2,595 at the start of the year. Since then, GNS stock has decreased by 13.1% and is now trading at GBX 2,254.

Genus plc (LON:GNS) posted its quarterly earnings results on Thursday, February, 26th. The company reported $60.80 EPS for the quarter. Genus had a trailing twelve-month return on equity of 9.70% and a net margin of 7.07%.
Read the conference call transcript
.

Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genus investors own include Meta Platforms (META), Lloyds Banking Group (LLOY), Rolls-Royce Holdings plc (RR.L), AstraZeneca (AZN), Barclays (BARC), BP (BP) and Clinigen Group (CLIN).

Company Calendar

Last Earnings
2/26/2026
Today
8/18/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Diversified Consumer Services
Sub-Industry
Specialized Consumer Services
Current Symbol
LON:GNS
CIK
N/A
Fax
N/A
Employees
480
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 3,350
Low Price Target
GBX 3,000
Potential Upside/Downside
+42.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 71
Trailing P/E Ratio
31.75
Forward P/E Ratio
31.76
P/E Growth
2.87
Net Income
£7.87 million
Net Margins
7.07%
Pretax Margin
N/A
Return on Equity
9.70%
Return on Assets
3.31%

Debt

Debt-to-Equity Ratio
51.73
Current Ratio
2.25
Quick Ratio
1.08

Sales & Book Value

Annual Sales
£672 million
Price / Sales
2.23
Cash Flow
GBX 44.58 per share
Price / Cash Flow
50.56
Book Value
GBX 827.95 per share
Price / Book
2.72

Miscellaneous

Outstanding Shares
66,413,000
Free Float
N/A
Market Cap
£1.50 billion
Optionable
Not Optionable
Beta
0.90
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:GNS) was last updated on 8/18/2026 by MarketBeat.com Staff.
From Our Partners